Janux Therapeutics (JANX) traded down -2.34 % during a 24 hours period ending at 03:42 AM Central Europe on Tuesday 27th. One Janux Therapeutics stock can currently be bought for about USD 16.69 on popular exchanges. Current supply of Janux Therapeutics stocks is 61.2 mn. Janux Therapeutics has a current market capitalization of USD 1 bn and approximately USD 6.3 mn worth of Janux Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Janux Therapeutics has traded -0.12 % down. Simple moving average of last 200 days is at USD 15.24. The highest price of past 52 weeks was recorded at USD 35.34 on 11/26/2025. 52 weeks low was at USD 12.12 on 02/05/2026.
Here is how related stocks have performed in the past 24 hours:
Opko Health (OPK) traded flat 0 % and now trades at USD 1.63. Current market capitalisation for Opko Health is USD 1.2 bn.
Goodrx (GDRX) traded down -2.21 % and now trades at USD 3.56. Current market capitalisation for Goodrx is USD 1.2 bn. Current price/earnings ratio for Goodrx is 74.53.
Enovis (ENOV) traded down -2.36 % and now trades at USD 21.16. Enovis has a market capitalisation of USD 1.2 bn.
Tandem Diabetes Care (TNDM) traded up 1.63 % and now trades at USD 18.9. Current market capitalisation for Tandem Diabetes Care is USD 1.2 bn.
Verastem (VSTM) traded down -0.2 % and now trades at USD 10. Current market capitalisation for Verastem is USD 1.2 bn.
About Janux Therapeutics
Janux Therapeutics, Inc. is a biotech company operating in the Health Care sector, offering immunotherapy treatments for cancer patients by redirecting their immune system to eliminate tumors to overcome their diseases. Additionally, the company provides testing services. Janux Therapeutics serves customers worldwide and can be accessed through their website at www.januxrx.com , traded on the Nasdaq stock exchange.